GRAY BRUCE HEALTH UNIT NEWS RELEASE ***************************
The Gray Bruce Health Department is pleased to announce that it has received a limited number of doses of the Novavax COVID-19 vaccine, which provides another option for people who wish to be vaccinated against the virus.
The protein-based, non-mRNA vaccine Novavax Nuvaxovid – approved by Health Canada in February for use in adults 18 years of age and older without contraindications – may be an alternative for people allergic to mRNA vaccines or for people who can’t or don’t want to. to receive an mRNA vaccine, according to the National Immunization Advisory Committee (NACI).
Novavax is the first recombinant protein subunit vaccine against COVID-19 to be approved in Canada. Protein subunit vaccines are already being used to protect people from other diseases, such as hepatitis B.
“We are excited to receive our first shipment of Novavax vaccines from the Gray Bruce Health Unit, which will support our goal of enabling as many people as possible to be immunized as soon as possible against COVID-19,” said Gray Bruce Health Consultant. to a doctor in the ward of Dr. Rim Zayed.
“This is important because we know that vaccination is the best protection against serious illness and death as a result of COVID-19, especially for people from high-risk populations.
Gray Bruce’s health unit is already contacting people who have added their name to the waiting list for Novavax. Others who are interested in getting the vaccine are asked to call public health at 519-376-9420.
More information about the Novavax Nuvaxovid COVID-19 vaccine can be found here.
NACI continues to recommend the preferential use of mRNA vaccines against COVID-19 for most people because of the excellent protection they provide against serious illness and hospitalization, and their well-known safety profiles.
*************************
Add Comment